Quantitative Proteomics and Metabolomics Analysis of Normal Human Cerebrospinal Fluid Samples*
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The analysis of cerebrospinal fluid (CSF) is used in biomarker discovery studies for various neurodegenerative central nervous system (CNS) disorders. However, little is known about variation of CSF proteins and metabolites between patients without neurological disorders. A baseline for a large number of CSF compounds appears to be lacking. To analyze the variation in CSF protein and metabolite abundances in a number of well-defined individual samples of patients undergoing routine, non-neurological surgical procedures, we determined the variation of various proteins and metabolites by multiple analytical platforms. A total of 126 common proteins were assessed for biological variations between individuals by ESI-Orbitrap. A large spread in inter-individual variation was observed (relative standard deviations [RSDs] ranged from 18 to 148%) for proteins with both high abundance and low abundance. Technical variation was between 15 and 30% for all 126 proteins. Metabolomics analysis was performed by means of GC-MS and nuclear magnetic resonance (NMR) imaging and amino acids were specifically analyzed by LC-MS/MS, resulting in the detection of more than 100 metabolites. The variation in the metabolome appears to be much more limited compared with the proteome: the observed RSDs ranged from 12 to 70%. Technical variation was less than 20% for almost all metabolites. Consequently, an understanding of the biological variation of proteins and metabolites in CSF of neurologically normal individuals appears to be essential for reliable interpretation of biomarker discovery studies for CNS disorders because such results may be influenced by natural inter-individual variations. Therefore, proteins and metabolites with high variation between individuals ought to be assessed with caution as candidate biomarkers because at least part of the difference observed between the diseased individuals and the controls will not be caused by the disease, but rather by the natural biological variation between individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Fluctuations of CSF amyloid-β levels: Implications for a diagnostic and therapeutic biomarker
Bateman, R. J., Wen, G., Morris, J. C., & Holtzman, D. M. (2007) · Neurology · doi:10.1212/01.wnl.0000256043.50901.e3 · Cited by 260
Lefranc, D., Vermersch, P., Dallongeville, J., Daems-Monpeurt, C., Petit, H., & Delacourte, A. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12774-9 · Cited by 47 · cited 2×
“A good example of this is apolipoprotein E, a protein that is reported to be present at lower concentrations in CSF of patients who have Alzheimer’s disease, regardless of age and gender variability (34).”
Background
Cited by
Modern analytical techniques in metabolomics analysis
Zhang, A., Sun, H., Wang, P., Han, Y., & Wang, X. (2012) · The Analyst · doi:10.1039/c1an15605e · Cited by 877
Vuckovic, D. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6039-y · Cited by 532
Smolinska, A., Blanchet, L., Buydens, L. M. C., & Wijmenga, S. S. (2012) · Analytica Chimica Acta · doi:10.1016/j.aca.2012.05.049 · Cited by 397
Self-citationMetabolome in progression to Alzheimer's disease
Orešič, M., Hyötyläinen, T., Herukka, S.-K., Sysi-Aho, M., Mattila, I., Seppänan-Laakso, T., Julkunen, V, Gopalacharyulu, P. V., Hallikainen, M., Koikkalainen, J., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.55 · Cited by 277
Recent and potential developments of biofluid analyses in metabolomics
Zhang, A., Sun, H., Wang, P., Han, Y., & Wang, X. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2011.10.027 · Cited by 276
Metadata
- Authors
- Stoop, M. P., Coulier, L., Rosenling, T., Shi, S., Smolinska, A. M., Buydens, L., Ampt, K., Stingl, C., Dane, A., Muilwijk, B., Luitwieler, R. L., Sillevis Smitt, P. A. E., Hintzen, R. Q., Bischoff, R., Wijmenga, S. S., Hankemeier, T., van Gool, A. J., & Luider, T. M.
- Venue
- Molecular & Cellular Proteomics
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 9
- Issue
- 9
- Pages
- 2063-2075
- ISSN
- 1535-9476 (ISSN-L)
- OpenAlex
- W4243609982
- Cited by
- 154
- References
- 3
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.